C. Neil Lyons
Director/Board Member at Panacela Labs, Inc.
Profile
C.
Neil Lyons is currently the Director at Panacela Labs, Inc. He previously worked as the CFO, Treasurer, CAO & Head-Investor Relations at RegeneRx Biopharmaceuticals, Inc. from 2005 to 2011.
He also worked as the Chief Financial Officer at HFS, Inc. and Vice President-Finance at SkyBridge LP.
From 1996 to 1998, he was a Senior Financial Executive at Bell Atlantic Corp.
He received his undergraduate degree from Florida Southern College.
C. Neil Lyons active positions
| Companies | Position | Start |
|---|---|---|
Panacela Labs, Inc.
 Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Director/Board Member | 31/03/2014 |
Former positions of C. Neil Lyons
| Companies | Position | End |
|---|---|---|
| STATERA BIOPHARMA, INC. | Director of Finance/CFO | 05/05/2016 |
| REGENERX BIOPHARMACEUTICALS, INC. | Director of Finance/CFO | 30/08/2011 |
| HFS, Inc. | Director of Finance/CFO | 19/04/2005 |
| SkyBridge LP | Director of Finance/CFO | 31/12/2002 |
| Bell Atlantic Corp. | Corporate Officer/Principal | 31/12/1997 |
Training of C. Neil Lyons
| Florida Southern College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
| HFS, Inc. | Commercial Services |
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Health Technology |
| Bell Atlantic Corp. | Communications |
| SkyBridge LP |
- Stock Market
- Insiders
- C. Neil Lyons
